Real-World Ocrelizumab Multiple Sclerosis Study Tracks Immunoglobulin Decline and Infection Risk
A retrospective cohort study found ocrelizumab induced predictable, class-specific immunoglobulin declines in multiple sclerosis patients without increasing short-to-mid-term clinically relevant ...












